Work

Supplementary Figure 7 from Preclinical Development of T Cells Engineered to Express a T-Cell Antigen Coupler Targeting Claudin 18.2–Positive Solid Tumors

Year: 2025

Type: supplementary-materials

Abstract: Supplementary Figure 7: N87CLDN18.2 tumor growth during primary and secondary tumor challenge in DKO mice treated with non-transduced T cells (NTD).

DOI: 10.1158/2326-6066.28171887

Authors: Stacey X. Xu, Ling Wang, Philbert Ip, Ritu R. Randhawa, Tania Benatar, Suzanna L. Prosser, Prabha Lal, Alima Naim Khan, Thanyashanthi Nitya-Nootan, Gargi Thakor, Heather MacGregor, Danielle L Hayes, Andrea Vucicevic, Princy Mathew, Sadhak Sengupta, Christopher W. Helsen, Andreas G. Bader

Language: English

Topic: CAR-T cell therapy research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4406227252

Cites:

Cited by:

Related to: 10